Anti-allergic Assessment of Ethanol Extractives of Quisqualis Indica Linn

Author:

Chaudhary Deepa1,Srivastava Rajnish2,Nagar Hemant3

Affiliation:

1. Department of Pharmacovigilance, All India Institute of Medical Sciences (AIIMS), Bhopal-462021, Madhya Pradesh, India

2. Moradabad Educational Trusts group of Institutions Faculty of Pharmacy, Moradabad-244001, Uttar Pradesh, India

3. Medicine Safety Monitoring Division, Central Drug Standard Control Organisation (HQ), New Delhi- 110002, India

Abstract

Aim: The present work was aimed at finding out the anti-allergic activity of ethanol extracts of Quisqualis indica Linn. (EEQI) by in-vitro and in-vivo murine models. Background: Worldwide, the rise in the prevalence of allergic diseases has continued in the industrialized world for more than 50 years. About 0.05-2% of the population is estimated to experience anaphylaxis at some point in life. Quisqualis indica Linn in an ornamental plant that has been rarely used as a herbal medicine, however, the presence of polyphenols and flavonoids have been reported to possess anti-inflammatory, antipyretic and immunomodulatory activity, which have some pathological relevance with anaphylaxis. Objective: The objective of the present research was to investigate, scientifically explore and understand the probable anti-anaphylactic mechanism of ethanol extracts of Quisqualis indica Linn. via different preclinical models. Material and Method: In-vitro study was done on de-granulated mesenteric mast cells induced by compound 48/80 and in-vivo study was done by Passive Cutaneous Anaphylaxis (PCA) model. In the in-vitro study degranulated mesenteric cells were grouped into negative control (compound 48/80 treated), positive control (Disodium cromoglycate + 48/80 treated) and 3 test groups (EEQI 10 μg/ml + 48/80 treated, EEQI 50 μg/ml + 48/80 treated and EEQI 100 μg/ml + 48/80 treated). The number of degranulated mast cells was counted and compared within the different treatment groups. In the in-vivo study, the rats were first grouped into negative control (vehicle only), positive control (Disodium cromoglycate) and 2 test groups (EEQI: 100 and 200 mg/kilogram). The animals were pretreated for 12 days. On the 12th day, all the rats were immunized with serum anti-ovalbumin (obtained from an already sensitized rat) by the intradermal route. After 24 h of serum injection, Evans blue dye containing oval albumin was administered intravenously in all groups. Three days later, the rats were taken down for the severity of the anaphylactic reactions. Result: EEQI significantly attenuates mast cell degranulation and maintains cell intactness as compared to control (P < 0.001). It was set up to support the degree of anaphylaxis as compared to the control group (P < 0.001). Conclusion: The outcomes of the work revealed the preventive effect of Quisqualis indica Linn. against allergic manifestations.

Publisher

Bentham Science Publishers Ltd.

Subject

General Pharmacology, Toxicology and Pharmaceutics

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3